Page 12 - 中国全科医学2022-05
P. 12

http://www.chinagp.net   E-mail:zgqkyx@chinagp.net.cn  ·521·


               DOI:10.1002/ehf2.13499.                         [25]OSMAN J,TAN S C,LEE P Y,et al. Sudden Cardiac Death (SCD)
           [15]FAXÉN J,JERNBERG T,HOLLENBERG J,et al. Incidence     - risk stratification and prediction with molecular biomarkers[J].
               and predictors of out-of-hospital cardiac arrest within 90 days after   J Biomed Sci,2019,26(1):39. DOI:10.1186/s12929-019-
               myocardial infarction[J]. J Am Coll Cardiol,2020,76(25):  0535-8.
               2926-2936. DOI:10.1016/j.jacc.2020.10.033.      [26]LEPOJÄRVI E S,HUIKURI H V,PIIRA O P,et al. Biomarkers
           [16]DOCHERTY K F,FERREIRA J P,SHARMA A,et al. Predictors   as predictors of sudden cardiac death in coronary artery disease
               of sudden cardiac death in high-risk patients following a myocardial   patients with preserved left ventricular function(ARTEMIS
               infarction[J]. Eur J Heart Fail,2020,22(5):848-855.   study)[J]. PLoS One,2018,13(9):e0203363. DOI:
               DOI:10.1002/ejhf.1694.                               10.1371/journal.pone.0203363.
           [17]LINDHOLM D,JAMES S K,GABRYSCH K,et al. Association   [27]GATZOULIS  K  A,TSIACHRIS  D,ARSENOS  P,et  al.
               of multiple biomarkers with risk of all-cause and cause-specific   Arrhythmic risk stratification in post-myocardial infarction
               mortality after acute coronary syndromes: a secondary analysis of the   patients with preserved ejection fraction:the PRESERVE EF
               PLATO biomarker study[J]. JAMA Cardiol,2018,3(12):   study[J]. Eur Heart J,2019,40(35):2940-2949. DOI:
               1160-1166. DOI:10.1001/jamacardio.2018.3811.         10.1093/eurheartj/ehz260.
           [18]ZEGARD A,OKAFOR O,DE BONO J,et al. Myocardial fibrosis   [28]XENOGIANNIS  I,GATZOULIS  K  A,FLEVARI  P,et  al.
               as a predictor of sudden death in patients with coronary artery   Temporal changes of noninvasive electrocardiographic risk factors
               disease[J]. J Am Coll Cardiol,2021,77(1):29-41. DOI:  for sudden cardiac death in post-myocardial infarction patients with
               10.1016/j.jacc.2020.10.046.                          preserved ejection fraction:Insights from the PRESERVE-EF
           [19]PAIMAN E H M,ANDROULAKIS A F A,SHAHZAD R,            study[J]. Ann Noninvasive Electrocardiol,2020,25(1):
               et al. Association of cardiovascular magnetic resonance-derived   e12701. DOI:10.1111/anec.12701.
               circumferential strain parameters with the risk of ventricular   [29]SOLOMON  S  D,ZELENKOFSKE  S,MCMURRAY  J  J,
               arrhythmia and all-cause mortality in patients with prior myocardial   et al. Sudden death in patients with myocardial infarction and
               infarction and primary prevention implantable cardioverter   left  ventricular  dysfunction,heart  failure,or  both[J].
               defibrillator[J]. J Cardiovasc Magn Reson,2019,21(1):  N  Engl  J  Med,2005,352(25):2581-2588.  DOI:
               28. DOI:10.1186/s12968-019-0536-5.                   10.1056/NEJMoa043938.
           [20]Use of cardiac MRI in early stages of STEMI to predict left ventricular   [30]HAANSCHOTEN D M,ELVAN A,RAMDAT MISIER A R,
               function recovery and ICD implantation (STEMI-MR)[EB/OL].   et al. Long-term outcome of the randomized DAPA trial[J]. Circ
               (2018-11-16)[2021-07-01]. https://clinicaltrials.gov/ct2/  Arrhythm Electrophysiol,2020,13(11):e008484. DOI:
               show/NCT03743935.                                    10.1161/CIRCEP.120.008484.
           [21]LEE  D  C,ALBERT  C  M,NARULA  D,et  al.  Estimating   [31]Personalised risk score for implantation of defibrillators in patients
               myocardial infarction size with a simple electrocardiographic marker   with preserved LVEF>35% and a high risk for sudden cardiac
               score[J]. J Am Heart Assoc,2020,9(3):e014205. DOI:   death[EB/OL]. (2020-09-07)[2021-07-09]. https://
               10.1161/JAHA.119.014205.                             clinicaltrials.gov/ct2/show/NCT04540289.
           [22]RIZAS K D,MCNITT S,HAMM W,et al. Prediction of sudden   [32]Personalised risk score for implantation of defibrillators in patients
               and non-sudden cardiac death in post-infarction patients with   with reduced LVEF ≤ 35% and a low risk for sudden cardiac death
               reduced left ventricular ejection fraction by periodic repolarization   (PROFID-Reduced)[EB/OL]. (2020-09-07)[2021-07-08].
               dynamics:MADIT-II substudy[J]. Eur Heart J,2017,38(27):  https://clinicaltrials.gov/ct2/show/NCT04540354.
               2110-2118. DOI:10.1093/eurheartj/ehx161.        [33]Programmed ventricular stimulation to risk stratify for early
           [23]DISERTORI  M,MASÈ  M,RIGONI  M,et  al.  Ventricular   cardioverter-defibrillator(ICD)  implantation  to  prevent
               tachycardia-inducibility predicts arrhythmic events in post-  tachyarrhythmias  following  acute  myocardial  infarction
               myocardial infarction patients with low ejection fraction. A systematic   (PROTECT-ICD)[EB/OL]. (2018-07-18)[2021-07-07].
               review and meta-analysis[J]. Int J Cardiol Heart Vasc,2018,  https://clinicaltrials.gov/ct2/show/NCT03588286.
               20:7-13. DOI:10.1016/j.ijcha.2018.06.002.       [34]Prognosis  impact  of  NSVTs  after  an  AMI(TeVeO  Study)
           [24]ADABAG S,ZIMMERMAN P,LEXCEN D,et al. Predictors of   [EB/OL].  (2021-02-23)[2021-07-01].  https://
               sudden cardiac arrest among patients with post-myocardial infarction   clinicaltrials.gov/ct2/show/NCT04765943.
               ejection fraction greater than 35[J]. J Am Heart Assoc,2021,  (收稿日期:2021-08-01;修回日期:2021-12-13)
               10(14):e020993. DOI:10.1161/JAHA.121.020993.                                    (本文编辑:李婷婷)
   7   8   9   10   11   12   13   14   15   16   17